Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
The development of a dose-dependent cardiomyopathy is the main limitation for the use of doxorubicin in chemotherapy protocols in both humans and animals. In this setting, the global myocardial function may be compromised resulting in signs of congestive heart failure. In this study, we investigated...
Enregistré dans:
Auteurs principaux: | Sousa,MG, Paulino-Junior,D, Pascon,JPE, Pereira-Neto,GB, Carareto,R, Camacho,AA |
---|---|
Langue: | English |
Publié: |
Facultad de Ciencias Veterinarias, Universidad Austral de Chile
2014
|
Sujets: | |
Accès en ligne: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0301-732X2014000100009 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Tei index of myocardial performance in conscious healthy Beagles
par: Sousa,MG, et autres
Publié: (2016) -
Impacto cardiovascular secundario a la terapia para el control del cáncer
par: Ríos,Juvenal A., et autres
Publié: (2020) -
Genetic basis of anthracyclines cardiotoxicity: Literature review
par: M. Yu. Sinitsky, et autres
Publié: (2021) -
Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography
par: Jingyuan Guan, et autres
Publié: (2021) -
<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
par: Alejandro Velasco-Ruiz, et autres
Publié: (2021)